Markers |
Cells |
n |
Mean |
SD |
Min |
Q1 |
Median |
Q3 |
Max |
p-value |
MMP2 |
Tumor |
30 |
64.85 |
26.87 |
12.1 |
45.63 |
72.71 |
85.99 |
99.27 |
0.7785 |
Stromal |
30 |
66.54 |
20.39 |
13.57 |
55.08 |
67.81 |
81.35 |
100.0 |
MMP9 |
Tumor |
26 |
54.68 |
31.59 |
0.71 |
28.61 |
55.49 |
85.62 |
100.0 |
0.2659 |
Stromal |
26 |
63.19 |
28.87 |
0.17 |
35.37 |
75.36 |
86.33 |
100.0 |
MMP14 |
Tumor |
27 |
80.18 |
26.26 |
17.21 |
54.27 |
100.0 |
100.0 |
100.0 |
0.0224 |
Stromal |
27 |
64.96 |
27.93 |
14.58 |
45.3 |
74.57 |
87.32 |
98.14 |
TIMP1 |
Tumor |
18 |
82.3 |
15.12 |
54.07 |
74.85 |
88.41 |
93.32 |
99.51 |
0.9072 |
Stromal |
18 |
82.76 |
16.03 |
33.94 |
76.74 |
86.15 |
94.26 |
98.96 |
TIMP2 |
Tumor |
19 |
44.3 |
19.65 |
14.69 |
28.59 |
42.47 |
53.01 |
78.76 |
0.0174 |
Stromal |
19 |
61.15 |
16.9 |
8.43 |
55.24 |
61.9 |
71.33 |
89.4 |
|
Comparisons between means were performed using the paired t-test |
Table 3: Comparison of mean percentages of tumor and stromal cells
immunopositive in Invasive Carcinoma (Group 2) |